129 related articles for article (PubMed ID: 28107261)
1. Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?
Negrão MV; Lima JM; Silva SC; Diz MD; da Costa Miranda V
Int J Gynecol Cancer; 2017 Mar; 27(3):543-549. PubMed ID: 28107261
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
[TBL] [Abstract][Full Text] [Related]
3. Para-aortic nodal metastases in cervical cancer: a blind spot in the International Federation of Gynecology and Obstetrics staging system: current diagnosis and management.
Hwang L; Bailey A; Lea J; Albuquerque K
Future Oncol; 2015; 11(2):309-22. PubMed ID: 25591841
[TBL] [Abstract][Full Text] [Related]
4. Para-aortic lymph node involvement in cervical cancer: Implications for staging, outcome and treatment.
Shylasree TS; Gurram L; Das U
Indian J Med Res; 2021 Aug; 154(2):267-272. PubMed ID: 35295007
[TBL] [Abstract][Full Text] [Related]
5. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.
Thelissen AAB; Jürgenliemk-Schulz IM; van der Leij F; Peters M; Gerestein CG; Zweemer RP; van Rossum PSN
Gynecol Oncol; 2022 Mar; 164(3):667-674. PubMed ID: 34969533
[TBL] [Abstract][Full Text] [Related]
6. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
[TBL] [Abstract][Full Text] [Related]
7. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
[TBL] [Abstract][Full Text] [Related]
9. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma.
Fastrez M; Goffin F; Vergote I; Vandromme J; Petit P; Leunen K; Degueldre M
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):895-901. PubMed ID: 23590725
[TBL] [Abstract][Full Text] [Related]
10. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
[TBL] [Abstract][Full Text] [Related]
11. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
[TBL] [Abstract][Full Text] [Related]
12. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: a review.
Smits RM; Zusterzeel PL; Bekkers RL
Int J Gynecol Cancer; 2014 Jul; 24(6):973-83. PubMed ID: 24978708
[TBL] [Abstract][Full Text] [Related]
14. Incidence of micrometastases in histologically negative para-aortic lymph nodes in advanced cervical cancer patients.
Martínez A; Mery E; Ferron G; Querleu D
Gynecol Oncol; 2010 Oct; 119(1):76-80. PubMed ID: 20667586
[TBL] [Abstract][Full Text] [Related]
15. The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience.
Manders DB; Sims TT; Bailey A; Hwang L; Richardson DL; Miller DS; Kehoe SM; Albuquerque KV; Lea JS
Am J Clin Oncol; 2018 Dec; 41(12):1225-1230. PubMed ID: 29782361
[TBL] [Abstract][Full Text] [Related]
16. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
17. Mapping patterns of para-aortic lymph node recurrence in cervical cancer: a retrospective cohort analysis.
Bae BK; Park SH; Jeong SY; Chong GO; Kim MY; Kim JC
Radiat Oncol; 2021 Jul; 16(1):128. PubMed ID: 34246296
[TBL] [Abstract][Full Text] [Related]
18. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
[TBL] [Abstract][Full Text] [Related]
19. How to predict para-aortic node involvement in advanced cervical cancer? Development of a predictive score. A FRANCOGYN study.
Nguyen-Xuan HT; Benoit L; Dabi Y; Touboul C; Raimond E; Ballester M; Bendifallah S; Collinet P; Kerbage Y; Ouldamer L; Bricou A; Lavoue V; Carcopino X; Huchon C
Eur J Surg Oncol; 2021 Nov; 47(11):2900-2906. PubMed ID: 34274203
[TBL] [Abstract][Full Text] [Related]
20. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
